Long-term survival in rhinocerebral mucormycosis: Case report

Bradley E. Weprin, Walter A. Hall, Jesse Goodman, George L. Adams

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Mucormycosis refers to a group of rapidly progressive infections caused by fungi belonging to the order Mucorales. Infection most often develops in individuals with immunological or metabolic compromise, although patients without underlying abnormalities have been affected. Specific clinical manifestations are associated with various predisposing factors. Rhinocerebral mucormycosis is the most common form and most frequently develops in individuals with poorly controlled diabetes mellitus. The extent of anatomical involvement and clinical course are unpredictable, depending on the intrinsic factors of the host. Over the past 20 years the prognosis for patients with rhinocerebral mucormycosis, once considered to be a uniformly fatal disease, has improved. Coordinated medical and surgical treatment, including rapid diagnosis, the advent of systemic antifungal agents, aggressive surgical debridement, and control of the underlying disease process, have been credited with its successful management. The range of survival rates recorded with the regimen of combined therapies is wide because the number of patients reported is limited and anatomical involvement is diverse. Survival with intracerebral abscess is rare. The authors describe the successful management of a patient who developed a bifrontal fungal abscess during treatment for rhinocerebral mucormycosis associated with ketoacidosis and diabetes mellitus. The patient remains without radiographic or clinical evidence of infection more than 2 years after treatment. The authors review the characteristic clinical, radiographic, and pathological features of previously reported infections and emphasize the importance of early detection and aggressive treatment in the management of this frequently fulminant and fatal disease.

Original languageEnglish (US)
Pages (from-to)570-575
Number of pages6
JournalJournal of Neurosurgery
Volume88
Issue number3
StatePublished - Mar 1998

Fingerprint

Mucormycosis
Survival
Abscess
Diabetes Mellitus
Mucorales
Infection
Therapeutics
Intrinsic Factor
Ketosis
Mycoses
Antifungal Agents
Debridement
Causality
Survival Rate

Keywords

  • Brain abscess
  • Fungus
  • Mucormycosis

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Weprin, B. E., Hall, W. A., Goodman, J., & Adams, G. L. (1998). Long-term survival in rhinocerebral mucormycosis: Case report. Journal of Neurosurgery, 88(3), 570-575.

Long-term survival in rhinocerebral mucormycosis : Case report. / Weprin, Bradley E.; Hall, Walter A.; Goodman, Jesse; Adams, George L.

In: Journal of Neurosurgery, Vol. 88, No. 3, 03.1998, p. 570-575.

Research output: Contribution to journalArticle

Weprin, BE, Hall, WA, Goodman, J & Adams, GL 1998, 'Long-term survival in rhinocerebral mucormycosis: Case report', Journal of Neurosurgery, vol. 88, no. 3, pp. 570-575.
Weprin, Bradley E. ; Hall, Walter A. ; Goodman, Jesse ; Adams, George L. / Long-term survival in rhinocerebral mucormycosis : Case report. In: Journal of Neurosurgery. 1998 ; Vol. 88, No. 3. pp. 570-575.
@article{727d21ff521646daaf1d450701ea9d60,
title = "Long-term survival in rhinocerebral mucormycosis: Case report",
abstract = "Mucormycosis refers to a group of rapidly progressive infections caused by fungi belonging to the order Mucorales. Infection most often develops in individuals with immunological or metabolic compromise, although patients without underlying abnormalities have been affected. Specific clinical manifestations are associated with various predisposing factors. Rhinocerebral mucormycosis is the most common form and most frequently develops in individuals with poorly controlled diabetes mellitus. The extent of anatomical involvement and clinical course are unpredictable, depending on the intrinsic factors of the host. Over the past 20 years the prognosis for patients with rhinocerebral mucormycosis, once considered to be a uniformly fatal disease, has improved. Coordinated medical and surgical treatment, including rapid diagnosis, the advent of systemic antifungal agents, aggressive surgical debridement, and control of the underlying disease process, have been credited with its successful management. The range of survival rates recorded with the regimen of combined therapies is wide because the number of patients reported is limited and anatomical involvement is diverse. Survival with intracerebral abscess is rare. The authors describe the successful management of a patient who developed a bifrontal fungal abscess during treatment for rhinocerebral mucormycosis associated with ketoacidosis and diabetes mellitus. The patient remains without radiographic or clinical evidence of infection more than 2 years after treatment. The authors review the characteristic clinical, radiographic, and pathological features of previously reported infections and emphasize the importance of early detection and aggressive treatment in the management of this frequently fulminant and fatal disease.",
keywords = "Brain abscess, Fungus, Mucormycosis",
author = "Weprin, {Bradley E.} and Hall, {Walter A.} and Jesse Goodman and Adams, {George L.}",
year = "1998",
month = "3",
language = "English (US)",
volume = "88",
pages = "570--575",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "3",

}

TY - JOUR

T1 - Long-term survival in rhinocerebral mucormycosis

T2 - Case report

AU - Weprin, Bradley E.

AU - Hall, Walter A.

AU - Goodman, Jesse

AU - Adams, George L.

PY - 1998/3

Y1 - 1998/3

N2 - Mucormycosis refers to a group of rapidly progressive infections caused by fungi belonging to the order Mucorales. Infection most often develops in individuals with immunological or metabolic compromise, although patients without underlying abnormalities have been affected. Specific clinical manifestations are associated with various predisposing factors. Rhinocerebral mucormycosis is the most common form and most frequently develops in individuals with poorly controlled diabetes mellitus. The extent of anatomical involvement and clinical course are unpredictable, depending on the intrinsic factors of the host. Over the past 20 years the prognosis for patients with rhinocerebral mucormycosis, once considered to be a uniformly fatal disease, has improved. Coordinated medical and surgical treatment, including rapid diagnosis, the advent of systemic antifungal agents, aggressive surgical debridement, and control of the underlying disease process, have been credited with its successful management. The range of survival rates recorded with the regimen of combined therapies is wide because the number of patients reported is limited and anatomical involvement is diverse. Survival with intracerebral abscess is rare. The authors describe the successful management of a patient who developed a bifrontal fungal abscess during treatment for rhinocerebral mucormycosis associated with ketoacidosis and diabetes mellitus. The patient remains without radiographic or clinical evidence of infection more than 2 years after treatment. The authors review the characteristic clinical, radiographic, and pathological features of previously reported infections and emphasize the importance of early detection and aggressive treatment in the management of this frequently fulminant and fatal disease.

AB - Mucormycosis refers to a group of rapidly progressive infections caused by fungi belonging to the order Mucorales. Infection most often develops in individuals with immunological or metabolic compromise, although patients without underlying abnormalities have been affected. Specific clinical manifestations are associated with various predisposing factors. Rhinocerebral mucormycosis is the most common form and most frequently develops in individuals with poorly controlled diabetes mellitus. The extent of anatomical involvement and clinical course are unpredictable, depending on the intrinsic factors of the host. Over the past 20 years the prognosis for patients with rhinocerebral mucormycosis, once considered to be a uniformly fatal disease, has improved. Coordinated medical and surgical treatment, including rapid diagnosis, the advent of systemic antifungal agents, aggressive surgical debridement, and control of the underlying disease process, have been credited with its successful management. The range of survival rates recorded with the regimen of combined therapies is wide because the number of patients reported is limited and anatomical involvement is diverse. Survival with intracerebral abscess is rare. The authors describe the successful management of a patient who developed a bifrontal fungal abscess during treatment for rhinocerebral mucormycosis associated with ketoacidosis and diabetes mellitus. The patient remains without radiographic or clinical evidence of infection more than 2 years after treatment. The authors review the characteristic clinical, radiographic, and pathological features of previously reported infections and emphasize the importance of early detection and aggressive treatment in the management of this frequently fulminant and fatal disease.

KW - Brain abscess

KW - Fungus

KW - Mucormycosis

UR - http://www.scopus.com/inward/record.url?scp=0031919432&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031919432&partnerID=8YFLogxK

M3 - Article

C2 - 9488314

AN - SCOPUS:0031919432

VL - 88

SP - 570

EP - 575

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 3

ER -